The board of directors of SSY Group Limited announced that the National Medical Products Administration of China has approved the passing of Consistency Evaluation of the Quality and Efficacy of generic Drugs for the Group's Gliclazide Tablets (80mg). Gliclazide Tablet is mainly used in adult patients with type 2 diabetes when dietary control, exercise, and weight loss are not enough to control blood sugar level.